Company intelligence / Profile preview

Retina Macula Institute

Torrance, California, United States
Ownership
Private
Employees
~30
Development stage
Other
01

Overview

Retina Macula Institute (RMI) is a specialized medical practice and clinical research center focused on the diagnosis and treatment of complex vitreoretinal and macular diseases. Founded in 2007 by Dr. Ron P. Gallemore, the institute operates state-of-the-art facilities in Torrance and Los Angeles, California. RMI provides advanced patient care, including intravitreal injections, photodynamic therapy, and complex retinal surgery. Additionally, the institute is a prominent clinical research site, participating in numerous Phase 1 through Phase 3 clinical trials for innovative ophthalmic therapies. These trials target conditions such as age-related macular degeneration, diabetic retinopathy, and geographic atrophy. With a commitment to both compassionate care and scientific advancement, RMI serves as a critical hub for retinal health in Southern California.

Therapeutic areas
OncologyOphthalmology
Modalities
Monoclonal antibody fragmentSmall moleculeRecombinant fusion proteinAptamerGene therapyDevice
Industry
Contract Research Organization
02

Partnerships

AlconRegeneronEyePoint PharmaceuticalsSanofiBoehringer Ingelheim

Beyond the preview

Go deeper on Retina Macula Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retina Macula Institute.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call